AzTrials
AzTrials

Caregiver BurdenNCT05996718

Improving Care Through Improv: Promoting Mastery in the Moment

A study testing Training program pilot in people with Caregiver Burden, run by Georgia State University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goals of this clinical trial are to: 1) refine the training program, "Improving Care though Improv;" and 2) test the program for its influence self-perceived caregiving mastery (i.e., how persons assess their ability to provide care) among informal caregivers of persons living with moderate dementia. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Caregiver Burden
What is being tested?
Training program pilot
Could I receive a placebo?
No, everyone receives an active treatment
How many people
43 participants
Where
1 siteUnited States
Study dates
25 Oct 2023to 20 May 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Actively engaged in the care of community-dwelling persons living with moderate dementia (4 or 5 on a 7-point dementia-staging scale) who is not likely to be institutionalized within the next 6 months
  • Able to attend at least 3 of the 4 in-person sessions
  • Ability to communicate in English
  • Exclusion Criteria: Potential participants were excluded if they did not meet the above criteria or anticipated moving their person to a skilled nursing facility within the next 6 months.

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Georgia State University

    Atlanta, Georgia, 30302

Other trials in United States

About this study

The goals of this clinical trial are to: 1) refine the training program, "Improving Care though Improv;" and 2) test the program for its influence self-perceived caregiving mastery (i.e., how persons assess their ability to provide care) among informal caregivers of persons living with moderate dementia. Forty-three informal caregivers will be involved in testing the training program. These individuals will be assigned to groups of between 8 to12 caregivers and take part in weekly 2-hour sessions held over a 4-week period. These caregivers will be taught improvisational (improv) theater skills, which involves being in the moment, self-awareness, and responsiveness to others. This group also will be asked to answer surveys questions about themselves and the person receiving care at three timepoints and invited to provide feedback on their training experiences.

Being tested
Training program pilot
Medical subject headings
Caregiver Burden

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Training program pilotBehavioural

    This intervention for informal caregivers consists of training that will introduce participants to improvisational (improv) theatre and teach its core communication skills.

Study groups in NCT05996718
Study groupRoleWhat they receive
Informal Caregivers of Persons Living with DementiaExperimentalParticipants will receive the training program, "Improving Care through Improv." This involves four weekly 2-hour in-person training sessions.
Receives: Behavioral: Training program pilot

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pearlin Mastery, Loss, and Competence: Caregiver Competence Subscale

    4-item Likert-type scale; scores range from 4 to 16 with higher scores indicating greater feelings of competence.

    Measured: at baseline, upon training completion (Week 4), and three months post baseline.

Secondary outcomes (7)
  1. Perceived Stress Scale

    14-item Likert-type scale. Scores range from 0 to 56 with higher scores indicating greater stress.

    Measured: at baseline, upon training completion (Week 4), and three months post baseline.

  2. Center for Epidemiological Studies-Depression Scale

    20-item Likert-type scale. Scores range from 0 to 60 with higher scores indicating greater depression.

    Measured: at baseline, upon training completion (Week 4), and three months post baseline.

  3. State-Trait Anxiety Inventory

    20-item Likert-type scale. Scores range from 20 to 80 with higher scores indicating greater anxiety.

    Measured: at baseline, upon training completion (Week 4), and three months post baseline.

  4. Zarit Burden Inventory

    22-item scale with 4-point Likert scale responses. Scores range from 0 to 88 with higher scores indicating greater burden.

    Measured: at baseline, upon training completion (Week 4), and three months post baseline.

  5. Revised Memory and Behavioral Problems Checklist - FREQUENCY

    24-item scale with 4-point Likert scale responses. Scores range from 0 to 96 with higher scores indicating greater behavioral expressions observed by caregivers among persons living with dementia.

    Measured: at baseline, upon training completion (Week 4), and three months post baseline.

  6. Quality of Life-Alzheimer's Disease Scale

    13 items with a 4-point Likert scale. Scores range from 13 to with 52 with higher scores indicating greater quality of life among persons living with dementia

    Measured: at baseline, upon training completion (Week 4), and three months post baseline.

  7. Revised Memory and Behavioral Problems Checklist - REACTION

    24-item scale with 4-point Likert scale responses. Scores range from 0 to 96 with higher scores indicating greater behavioral expressions observed by caregivers among persons living with dementia.

    Measured: at baseline, upon training completion (Week 4), and three months post baseline.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Aug 2023
  2. Study start25 Oct 2023
  3. Primary completion20 May 2024
  4. Study completion20 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
43 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05996718
Sponsor's protocol ID
P30AG064200
Other IDs
DBSR-11114, P30AG064200
Status last verified
Jun 2025
First submitted
10 Aug 2023
Last updated
11 Jun 2025
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Data from this study will be made available to qualified researchers through a data sharing agreement that is consistent with NIH data sharing policies, as well as policies and practices established by the Roybal Center for Dementia Caregiving Mastery at Emory University. The data to be collected include common data elements, including the Caregiver Mastery Scale developed by Pearlin and colleagues, as well as demographic characteristics. Although these data will be de-identified prior to release for sharing, there remains a possibility of deductive disclosure of participants with unusual characteristics. Therefore, this data sharing agreement will require: 1) a commitment only to use the data for research purposes and not to identify any individual participant; 2) a commitment to securing the data using appropriate computer technology; and 3) a commitment to destroy or return the data after analyses are completed.

Publications

  • Kemp CL, Anglin E, Morgan JC, Johnson Ii TM. Improving Care through Improv: pilot test results of an innovative training program for care partners of people living with dementia. Gerontologist. 2026 Mar 9;66(4):gnaf240. doi: 10.1093/geront/gnaf240.

    PubMed 41181875

Questions about this trial

What is this clinical trial studying?

A study testing Training program pilot in people with Caregiver Burden, run by Georgia State University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 11 Jun 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pearlin Mastery, Loss, and Competence: Caregiver Competence Subscale (time frame: at baseline, upon training completion (Week 4), and three months post baseline.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05996718, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in